Hi ,

In case you missed it, I joined Karl Schmieder and Erum Khan of Messaginglab on the Grow Everything podcast last week. We explored how biotechnology is merging with other sectors, such as space exploration, and how synthetic biology is reshaping the future. We talked about how biotech can help solve global problems, from environmental to health issues. Listen now.

Karl and Erum will be at SynBioBeta this year, and you can join them! For a limited time, save over $800 when you purchase your conference ticket for SynBioBeta 2024 using promo code AIxBIO-200 (expires on Friday, 2/9).

Sponsors / Exhibitors coming to SynBioBeta 2024:

  • Asimov builds tools to program living cells. They're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

  • MITRE is a not-for-profit corporation committed to the public interest, operating federally funded R&D centers on behalf of U.S. government sponsors.

  • Elegen is powering the bioeconomy with high-accuracy DNA synthesis that delivers industry-leading speed, length, and quality.

  • Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.

  • Elo Life Systems is a biotechnology company that focuses on human health and wellness through food.

You’ll also be able to meet people from these organizations that just registered: Lululemon, OpenAI, Protera, Codexis, Innovative Genomics Institute, IBioIC, SynbiCITE, Novozymes, Khosla Ventures, L’oreal Research & Innovation, AbbVie, and more.

Speakers include:

Register now

Insights (Exclusive Content):

SynBioBeta’s Annual Synthetic Biology Investment Report: Insights Into What Could Be In Store for ‘24

On February 21, 11 am ET, John and Mark will discuss the details of the soon-to-be-released 2024 SynBioBeta Annual Investment Report and, more importantly, how you can get a copy! Register now.

Industry News:

Keith Wood, CEO of Light Bio, at SynBioBeta.

Other news:

 J. Casey Lippmeier, senior vice president of innovation, Conagen, at SynBioBeta.

Paul Kohlhaas, CEO of Molecule, speaking at SynBioBeta.

Who's hiring?

Email Marketing by ActiveCampaign